• Bridging the gap: metabolic and endocrine care of patients during transition.

      Hokken-Koelega, A; van der Lely, A; Hauffa, B; Häusler, G; Johannsson, G; Maghnie, M; Argente, J; DeSchepper, J; Gleeson, H; Gregory, J; et al. (2016-11)
      Seamless transition of endocrine patients from the paediatric to adult setting is still suboptimal, especially in patients with complex disorders, i.e., small for gestational age, Turner or Prader-Willi syndromes; Childhood Cancer Survivors, and those with childhood-onset growth hormone deficiency.
    • Growth Hormone Research Society perspective on biomarkers of GH action in children and adults.

      Johannsson, G; Bidlingmaier, M; Biller, B; Boguszewski, M; Casanueva, F; Chanson, P; Clayton, P; Choong, C; Clemmons, D; Dattani, M; et al. (2018-03)
      The Growth Hormone Research Society (GRS) convened a Workshop in 2017 to evaluate clinical endpoints, surrogate endpoints and biomarkers during GH treatment of children and adults and in patients with acromegaly.